US Patent Issued on April 21 for "Antibodies targeting integrin beta-2" (Canadian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,628, issued on April 21.

"Antibodies targeting integrin beta-2" was invented by Sachdev Singh Sidhu (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that specifically target integrin beta-2 and compositions comprising such antibodies for therapeutic and diagnostic applications. The antibodies comprise an integrin beta-2 binding domain comprising a heavy chain variable region comprising an HCDR1 sequence comprising ISYYYM, an HCDR2 sequence comprising SISSSSGYTY; and an HCDR3 sequence comprising GAM; and a light chain variable region comprising an LCDR1 sequence comprising SVSSA, an LCDR2 sequence comprising SAS...